Time course and mechanism of myocardial catecholamine release during transient ischemia in vivo

Circulation

Volumn 101, Issue 22, 2000, Pages 2645-2650

  Lameris, Thomas W ^a,b   De Zeeuw, Sandra ^a   Alberts, Gooitzen ^a   Boomsma, Frans ^a   Duncker, Dirk J ^a   Verdouw, Pieter D ^a   Man In 't Veld, Arie J ^a   Van Den Meiracker, Anton H ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Microdialysis; Myocardial infarction; Nervous system, autonomic

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOPAMINE; NORADRENALIN; TYRAMINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASE; CATECHOLAMINE RELEASE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART INFARCTION; ISCHEMIC HEART DISEASE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0034612305     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.22.2645     Document Type: Article

References (35)

1. Akiyama T, Yamazaki T, Ninomiya I. Differential regional responses of myocardial interstitial noradrenaline levels to coronary occlusion. Cardiovasc Res. 1993;27:817-822.
2. Schomig A, Dart AM, Dietz R, et al. Release of endogenous catecholamines in the ischemic myocardium of the rat, part A: locally mediated release. Circ Res. 1984;55:689-701.
3. Shindo T, Akiyama T, Yamazaki T, et al. Increase in myocardial interstitial norepinephrine during a short period of coronary occlusion. J Auton Nerv Syst. 1994;48:91-96.
4. Shindo T, Akiyama T, Yamazaki T, et al. Regional myocardial interstitial norepinephrine kinetics during coronary occlusion and reperfusion. Am J Physiol. 1996;270:H245-H251.
5. Kranzhofer R, Haass M, Kurz T, et al. Effect of digitalis glycosides on norepinephrine release in the heart: dual mechanism of action. Circ Res. 1991;68:1628-1637.
6. Kurz T, Richardt G, Hagl S, et al. Two different mechanisms of noradrenaline release during normoxia and simulated ischemia in human cardiac tissue. J Mol Cell Cardiol. 1995;27:1161-1172.
7. Kurz T, Offner B, Schreieck J, et al. Nonexocytotic noradrenaline release and ventricular fibrillation in ischemic rat hearts. Naunyn-Schmiedebergs Arch Pharmacol. 1995;352:491-496.
8. Esler M, Eisenhofer G, Dart A, et al. Adrenaline release by the human heart. Clin Exp Pharmacol Physiol. 1991;18:67-70.
9. Esler M, Kaye D, Thompson J, et al. Effects of aging on epinephrine secretion and regional release of epinephrine from the human heart. J Clin Endocrinol Metab. 1995;80:435-442.
10. Huang MH, Friend DS, Sunday ME, et al. An intrinsic adrenergic system in mammalian heart. J Clin Invest. 1996;98:1298-1303.
11. Kaye DM, Lefkovits J, Cox H, et al. Regional epinephrine kinetics in human heart failure: evidence for extra-adrenal, nonneural release. Am J Physiol. 1995;269:H182-H188.
12. Lameris TW, van Den Meiracker AH, Boomsma F, et al. Catecholamine handling in the porcine heart: a microdialysis approach. Am J Physiol. 1999;277:H1562-H1569.
13. Yamazaki T, Akiyama T. Effects of locally administered desipramine on myocardial interstitial norepinephrine levels. J Auton Nerv Syst. 1996;61: 264-268.
14. + channels. Circulation. 1996;93:178-186.
15. Bier J, Sharaf B, Gewirtz H. Origin of anterior interventricular vein blood in domestic swine. Am J Physiol. 1991;260:H1732-H1736.
16. Boomsma F, Alberts G, van Eijk L, et al. Optimal collection and storage conditions for catecholamine measurements in human plasma and urine. Clin Chem. 1993;39:2503-2508.
17. Alberts G, Lameris T, van den Meiracker AH, et al. Sensitive and specific method for the simultaneous determination of natural and synthetic catecholamines and 3,4-dihydroxyphenylglycol in microdialysis samples. J Chromatogr B Biomed Sci Appl. 1999;730:213-219.
18. Verdouw PD, Schamhardt HC, Remme WJ, et al. Antiarrhythmic, metabolic and hemodynamic effects of Org 6001 (3alpha-amino-5alpha-androstan-2beta-ol-17-one-hydrochloride) after coronary flow reduction in pigs. J Pharmacol Exp Ther. 1978;204:634-644.
19. van der Hoom FA, Boomsma F, Man in 't Veld AJ, et al. Determination of catecholamines in human plasma by high-performance liquid chromatography: comparison between a new method with fluorescence detection and an established method with electrochemical detection. J Chromatogr. 1989;487:17-28.
20. Akiyama T, Yamazaki T, Ninomiya I. In vivo monitoring of myocardial interstitial norepinephrine by dialysis technique. Am J Physiol. 1991;261: H1643-H1647.
21. Sunn N, Harris PJ, Bell C. Effects on renal sympathetic axons in dog of acute 6-hydroxydopamine treatment in combination with selective neuronal uptake inhibitors. Br J Pharmacol. 1990;99:655-660.
22. Amara SG, Kuhar MJ. Neurotransmitter transporters: recent progress. Annu Rev Neurosci. 1993;16:73-93.
23. Schomig A. Adrenergic mechanisms in myocardial infarction: cardiac and systemic catecholamine release. J Cardiovasc Pharmacol. 1988; 12(suppl 1):S1-S7.
24. Headrick JP. Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine. J Mol Cell Cardiol. 1996;28:1227-1240.
25. Seyfarth M, Feng Y, Hagl S, et al. Effect of myocardial ischemia on stimulation-evoked noradrenaline release: modulated neurotransmission in rat, guinea pig, and human cardiac tissue. Circ Res. 1993;73:496-502.
26. Eisenhofer G, Esler MD, Cox HS, et al. Differences in the neuronal removal of circulating epinephrine and norepinephrine. J Clin Endocrinol Metab. 1990;70:1710-1720.
27. Kennedy B, Ziegler MG. Cardiac epinephrine synthesis: regulation by a glucocorticoid. Circulation. 1991;84:891-895.
28. Thompson JM, Wallin BG, Lambert GW, et al. Human muscle sympathetic activity and cardiac catecholamine spillover: no support for augmented sympathetic noradrenaline release by adrenaline co-transmission. Clin Sci (Colch). 1998;94:383-393.
29. Yamazaki T, Akiyama T, Kitagawa H, et al. A new, concise dialysis approach to assessment of cardiac sympathetic nerve terminal abnormalities. Am J Physiol. 1997;272:H1182-H1187.
30. Cardinal R, Nadeau R, Novak V. Reduced capacity of cardiac efferent sympathetic neurons to release norepinephrine and modify cardiac function in tachycardia-induced canine heart failure. Can J Physiol Pharmacol. 1996;74:1070-1078.
31. Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol. 1985;17: 291-306.
32. Cruickshank JM, Neil-Dwyer G, Degaute JP, et al. Reduction of stress/ catecholamine-induced cardiac necrosis by beta 1-selective blockade. Lancet. 1987;2:585-589.
33. 2+ transport due to excess catecholamines. Cardiovasc Drugs Ther. 1996;10(suppl 1):231-238.
34. Rump AF, Klaus W. Evidence for norepinephrine cardiotoxicity mediated by superoxide anion radicals in isolated rabbit hearts. Naunyn-Schmiedebergs Arch Pharmacol. 1994;349:295-300.
35. Du XJ, Woodcock EA, Little PJ, et al. Protection of neuronal uptake-1 inhibitors in ischemic and anoxic hearts by norepinephrine-dependent and -independent mechanisms. J Cardiovasc Pharmacol. 1998;32:621-628.